| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.006 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |